...
首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
【24h】

Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.

机译:散发性结直肠癌中的吸烟和KRAS致癌基因突变:荷兰队列研究的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

Since a KRAS oncogene mutation is an early event in colorectal cancer development and cigarette smoking is thought to have an effect on early stages of colorectal tumorigenesis, smoking, especially long-term smoking, may be associated with the risk for colorectal cancer with KRAS oncogene mutations. In the Netherlands Cohort Study on diet and cancer (n=120,852 men and women), using a case-cohort design, adjusted incidence rate ratios (RR) and 95% confidence intervals (CI) were computed for colorectal tumors with wild-type and with mutated KRAS gene, and with specific G:C-->T:A or G:C-->A:T point mutations in KRAS, according to cigarette smoking status, frequency, duration, pack years, age at first exposure, years since cessation, inhalation and filter usage. After 7.3 years and excluding the first 2.3 years, 648 cases and 4083 sub-cohort members were included in the analyses. Ex-smokers, but not current smokers, were at increased risk for colorectal cancer with wild-type KRAS gene tumors when compared with never smokers, albeit not statistically significant (RR 1.26, 95% CI 0.96-1.66). This was not observed for KRAS mutated tumors when comparing ex-smokers with never smokers (RR 1.15, 95% CI 0.79-1.66). The highest category of smoking frequency (>20 cigarettes/day) and inhalation of smoke were associated with an increased risk for colorectal cancer with wild-type KRAS gene tumors, though not statistically significant, when compared with never smoking (frequency: RR 1.24, 95% CI 0.90-1.71 and inhalation: RR 1.25, 95% CI 0.94-1.67). These associations were strongest in men (ex-smokers: RR 1.79, 95% CI 1.00-3.20; frequency: RR 1.91, 95% CI 1.03-3.52; inhalation: RR 1.69, 95% CI 0.94-3.04). No associations were observed between any of the smoking characteristics and the risk for colorectal cancer with mutated KRAS gene tumors, nor where there any clear associations with tumors with specific G:C-->A:T transitions or G:C-->T:A transversions. These results suggest that, in contrast to the hypothesis, smoking doesnot increase the risk for colorectal tumors with a mutated KRAS gene. Some smoking characteristics, i.e. being an ex-smoker, frequency and inhalation, may be associated with risk for colorectal cancer characterized by the wild-type KRAS gene, especially in men.
机译:由于KRAS致癌基因突变是结直肠癌发展的早期事件,并且吸烟被认为对结直肠肿瘤发生的早期阶段有影响,因此吸烟(尤其是长期吸烟)可能与具有KRAS致癌基因突变的结直肠癌风险相关。在荷兰的饮食与癌症队列研究(男性和女性n = 120,852)中,采用病例队列设计,计算了野生型和大肠癌的经调整的发生率(RR)和95%置信区间(CI)。具有KRAS基因突变,并根据吸烟状况,吸烟频率,持续时间,包装年限,首次接触年龄,在KRAS中具有特定的G:C-> T:A或G:C-> A:T点突变,戒烟,吸入和使用过滤器已有数年历史。在7.3年后(不包括前2.3年),分析了648例病例和4083个亚组成员。与不吸烟者相比,前吸烟者(而不是当前吸烟者)罹患具有野生型KRAS基因肿瘤的结直肠癌的风险增加,尽管无统计学意义(RR 1.26,95%CI 0.96-1.66)。比较前吸烟者和从不吸烟者时未观察到KRAS突变的肿瘤(RR 1.15,95%CI 0.79-1.66)。与从未吸烟者相比,最高吸烟频率类别(> 20支香烟/天)和烟气吸入与野生型KRAS基因肿瘤的大肠癌风险增加相关,尽管无统计学意义(频率:RR 1.24, 95%CI 0.90-1.71和吸入:RR 1.25,95%CI 0.94-1.67)。这些关联在男性中最强(前吸烟者:RR 1.79,95%CI 1.00-3.20;频率:RR 1.91,95%CI 1.03-3.52;吸入:RR 1.69,95%CI 0.94-3.04)。没有观察到任何吸烟特征与KRAS基因突变的大肠癌风险之间的关联,也没有发现与特定G:C-> A:T转变或G:C-> T的肿瘤有明确的关联:A颠覆。这些结果表明,与假设相反,吸烟不会增加具有突变的KRAS基因的大肠肿瘤的风险。某些吸烟特征(例如,前吸烟者,吸烟次数和吸入次数)可能与以野生型KRAS基因为特征的结直肠癌风险有关,尤其是在男性中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号